ABSTRACT
Evidence from the literature pointed to the possibility of an antigen/superantigenic drive on the BCR during lymphomagenesis, resulting in the biased usage of certain V genes by B-cell tumors. In CLL, this is reflected by the marked overexpression of IGHV1-69 in U-CLL and of IGHV4-34 in M-CLL. 19, 20 Usage of the IGHV3-21 gene is an independent unfavorable prognostic factor irrespective of IGHV gene mutational status, 21 and a subset of CLL using IGHV3-21 had a very short, highly similar, heavy complementary determining region 3 (HCDR3), showing biased utilization of the IGHV3-21 gene. 22 Recent studies reported a lower incidence of IGHV3-21 CLL in Mediterranean countries and a higher incidence in northern European countries, thus suggesting that the frequency of IGHV3-21 CLL may be related to geographic, ethnic, or environmental background. 23, 24 These observations led to the speculation that CLL pathogenesis may involve specific, unidentified (auto)antigens. 25 The biased ethnic and geographic variants of clinical course and IGH gene usage, which may reflect different genetic backgrounds and/or an effect of environmental factors, prompted us to provide a comprehensive characterization of 75 CLL cases collected at two reference centers in Europe (Siena, Italy) and in Africa (Dakar, Senegal) in terms of mutational status of the IGH gene by a next-generation sequencing (NGS) approach.
Materials and Methods

Case Selection and Workflow
We collected peripheral blood mononuclear cells (PBMCs) from a total of 75 patients with CLL, 25 from Senegal, Africa (20 men and five women), and 50 from Siena, Italy (27 men and 23 women). Since it is well known that there are differences in germline IGH repertoires between different populations, 26 we also collected PBMCs from five healthy Senegalese individuals as control.
Diagnosis was based on morphologic and immunophenotypical findings according to the World Health Organization (WHO) classification. 1 Samples were collected before any treatment, and clinical characteristics were provided by referring physicians. The study was approved by each institutional ethical committee, and written permission and informed consent were obtained before sample collection in accordance with the Declaration of Helsinki.
Polymerase Chain Reaction Amplification and High-Throughput Sequencing
Total RNA was extracted from CLL samples with Trizol according to the manufacturer's procedure (Invitrogen, Life Technologies, Carlsbad, CA). In total, 1 µg total extracted RNA per case was transcribed into complementary DNA using the QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Resulting cDNA was subjected to polymerase chain reaction amplification of the IGVH locus by using modified BIOMED-2 framework region 1 consensus primers in conjunction with a consensus J segment primer, as previously described. 27 Data analysis was performed using the Roche (Basel, Switzerland) proprietary software package for the 454 GS Junior system (Roche). Image acquisition, image processing, and signal processing were performed during the run.
Bioinformatical Analysis
The bioinformatical analysis was performed by using the 454 GS Junior system, as previously described.
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Sequence Data Analysis
To determine the IGHV, IGHD, and IGHJ gene usage and the mutational status of each IGHV gene, sequences were submitted to the international ImmunoGeneTics database (IMGT, Montpellier, France) 28, 29 and aligned to the closest matching germline gene by using the IMGT/V-QUEST and IMGT/Junction Analysis software, 30,31 as previously described.
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Clustering of VH CDR3 Sequences
The length of the VH CDR3 of the immunoglobulin heavy chain gene rearrangement was computed using the IMGT database starting from the first codon after the conserved cysteine up to the position preceding the conserved tryptophan of the JH gene segment, as previously described. 18, 19, 24 
Statistical Analysis
Statistical analyses were performed using SPSS software (SPSS, Chicago, IL). The Student t test was used for comparison of continuous variables (eg, lymphocyte count); χ 2 and, when appropriate (particularly when the group's dimension was below 10 elements), Fisher exact test were used for the remaining comparisons. The limit of significance for all analyses was defined as P < .05.
Results
Distribution of VH Families in Senegalese Healthy Individuals
A total of 26,053 IGH productive rearrangements were obtained from the peripheral blood of five healthy Senegalese donors (three men and two women; age range, 50-70 years). Analysis of the distribution of IGH families in these cases showed a higher usage of IGHV3 (53.35%) followed by IGHV4 (32.62%), while IGHV1 and IGHV2 represented together only 9.26%. Specifically, the more frequent IGHV genes were IGHV4-59/61 (16.39%), IGHV3-48 (10.48%), IGHV3-23 (9.45%), and IGHV4-39 (6.3%). The more common D segments were D3-3 and D2-2 (20% and 18%, respectively), while the more common J segments were J6 and J4 (40% and 32%, respectively).
Senegalese CLL Cases More Often Present With Unfavorable Prognostic Features
The main clinical features of the Senegalese and Italian cohort are shown in ❚Table 1❚ and ❚Figure 1❚. Interestingly, at diagnosis, 19 (76%) of 25 Senegalese patients were more frequently symptomatic when they arrived at the medical center and had an advanced Binet clinical stage. Specifically, six (24%) patients were in stage A, five (20%) in stage B, and 14 (56%) in stage C. On the contrary, 38 (76%) Italian patients were in stage A, 9 (18%) in stage B, and only 3 (6%) in stage C ( Figure 1A) .
Senegalese patients presented with a higher lymphocyte count (median, 88.6 vs 13.8 × 10
9 /L, P < .001) ( Figure 1B ), lower hemoglobin levels (9.7 vs 13.7 g/dL, P <.001) ( Figure 1C ), and more frequent CD38 expression ( Figure 1D ).
IGVH Is More Frequently Unmutated in Senegalese Cases
A total of 98,033 reads corresponding to productive IGH rearrangements were obtained by NGS technology, from the entire cohort of the 25 Senegalese patients with CLL; one sample of 25 showed a polyclonal GeneScan and NGS analysis and was excluded from further analysis. For the Italian cohort, a total of 234,000 IGH productive rearrangements were evaluated. Interestingly, using the conventional 2% cutoff to discriminate between mutated (M) and unmutated (UM) rearrangements, 19 (79%) of 24 Senegalese patients had UM IGH genes, with 13 (54%) patients in 100% germline configuration and six with a 99.1% to 99.55% identity to the germline, whereas the remaining five (21%) patients were defined as M, with a median of 12 (range, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Overall, these data indicate a remarkable biological difference between Senegalese and Italian CLL cases, with a significantly higher frequency of UM IGHV status in the Senegalese cohort.
Distribution of VH Families in Patients With CLL From Senegal
In the Senegalese group, the analysis of the IGH subgroups revealed that the most commonly represented IGH family was IGHV1 (10/24, 41%), followed by IGHV3 (9/24, 37%) and IGHV4 (5/24, 20%), with the most frequently encountered being IGHV1-69 ( Table  1) . Then we tested whether the IGH usage of Senegalese CLL was derived randomly from the V segment repertoire expressed in normal peripheral blood lymphocytes in the same ethnic setting or whether they exhibited a biased V segment usage, and we found that the IGHV1 genes were significantly overrepresented in CLL ( χ 2 , P = .0003) with a remarkably biased usage of IGHV1-69 in CLL ( χ 2 , P = .00002). IGHD3 was the most frequently represented (18/24, 75%), followed by IGHD4 (2/24, 8.3%). The IGHD3-3*1 gene and allele (12/24, 50%) was the most frequently used, followed by IGHD3-10 (2/24, 8.3%) (Supplementary Table 1) .
With regard to the IGHJ gene usage, the most frequent subgroup was IGHJ4, which has been represented in 11 (45.83%) of 24 cases, followed by IGHJ6, which has been found in 10 (41.67%) of 24 cases (Supplementary Table 1 We also confirmed the presence of specific V-D-J segment combinations; in particular, the IGHV1-69 gene was more frequently associated with IGHD3-3*01 (5/8 cases, 62.5%), IGHJ4 segments (4/8 cases, 50%), and IGHJ6 segments (3/8 cases, 37.5%), whereas IGHV3-23 was univocally associated with IGHJ4 segments (2/2 cases, 100%).
The median length of HCDR3 was 18.5 amino acids (range, 9-29). UM sequences had significantly longer HCDR3s than mutated sequences: median length, 20 (10-29) vs 13 (9-16) amino acids (P = .01). Finally, IGHV chain and CDR3 from our CLL data set were aligned, and stereotyped rearrangements were evaluated according to a previously reported study. 32 Our data were compared with the six principal subsets (1, 2, 3, 4, 6, and 8) found in literature. 32 No stereotyped rearrangements could be found based on such criteria.
Distribution of VH Families in Patients With CLL From Italy
When we examined the IGH specific genes, the most frequently encountered were the IGHV3-7 gene (6/50 cases, 12%) and IGHV3-30 gene (5/50 cases, 10%), followed by the IGHV3-21 gene (4/50 cases, 8%) ❚Figure 3B❚ (Supplementary Table 2 ). In our cohort, we also confirmed the known low frequency of the IGHV3-21 gene in patients with CLL of Mediterranean origin (4/50, 8%), in agreement with previous data ( Figure 3B ).
Concerning IGHD, the most frequently used subgroups were IGHD2 (15/50, 30%) and IGHD3 family (15/50, 30%) (Supplementary Table 2 ). The most prevalent gene was IGHD3-16 (6/50, 12%).
Regarding IGHJ gene usage, among Italian patients, there was an overrepresentation of the IGHJ4 (25/50, 50%) and IGHJ6 (12/50, 24%) genes.
The HCDR3 median length was 15 amino acids (range, . Significantly longer HCDR3s were observed in UM vs M sequences (median lengths, 18 vs 14 amino acids; t test, P = .005). IGHV chain and CDR3 were then aligned and stereotyped rearrangements were evaluated according to the previous experience. 32 Stereotyped receptors were observed in three cases, with two corresponding to "subset 2" and one to "subset 3."
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Italian and Senegalese CLL Present Differences in IGHV Gene Repertoire
We last compared the usage of IGH genes in Senegalese and Italian cases. The most represented IGHV family in Senegalese patients was IGHV1, whereas in Italian patients, it was IGHV3. Specifically, in Senegalese samples, 33% of cases used the IGHV1-69 gene and no one the IGHV3-30 gene (P < .0001). Regarding the frequency of individual V segments, the IGHV1-69 segment was used only in the UM configuration. In contrast, in Italian patients, the most represented IGHV gene was IGHV3-7 (12%), followed by IGHV3-30 (10%). The IGHV1-69 segment was used only in two (4%) Italian cases, both in the unmutated configuration. The IGHV3-7 gene was used in the M configuration in 12% of cases and the IGHV3-30 gene in 8% ❚Figure 4A❚. Since a possible bias toward UM biology was observed in Senegalese patients, we also compared the IGH repertoires in UM cases only. Intriguingly, a significant difference in IGHV1-69 usage was still evident with two of 15 Italian vs eight of 19 Senegalese patients with this pattern (Fisher exact test, P = .05) ❚Figure 4B❚.
Similarly, the usage of IGHD genes was significantly different in the two groups ( χ 2 , P = .015). In particular, the IGHD3 subgroup was significantly increased in Senegalese CLL compared with Italian CLL ( χ 2 , P = .0002), this being mainly related to a significant overrepresentation of the IGHD3-3 gene (P < .0001); moreover, in Senegalese patients, the IGHD3-3 gene was used mainly in UM cases. By contrast, IGHD2 was overrepresented ( χ 2 , P = .01) in Italian CLL and mainly used in M cases.
With regard to the IGHJ gene usage, there were no differences in IGHJ4 usage (45.83% in Senegalese patients and 50% in Italian patients), although in the Italian cohort, it was mainly used in M cases, whereas IGHJ6 was most frequent in the Senegalese cohort (41.67% vs 24% in the Italian cohort) (P < .05). Overall, these data indicate that different IGHV usage characterizes Senegalese and Italian CLL cases.
Discussion
CLL is a lymphoproliferative disorder mostly affecting patients older than 64 years. 1 The average age observed in our series from Senegal was comparable with data from the WHO classification while slightly lower than what was observed in the present Italian series. 1, [3] [4] [5] Although CLL is relatively common among adults in the Western world, it is rarer in East Asia and in developing countries, mainly in Africa. 4, 33, 34 A few studies on CLL in sub-Saharan and Asian/Pacific Islander populations reported a younger age of onset and a more aggressive course than in Western countries. 33, 35, 36 The variable course of CLL is driven, at least in part, by heterogeneity in the disease biology. Among several parameters, UM IGH proved to be still a robust unfavorable prognostic marker. 37, 38 We observed a strong predominance of UM cases in the Senegalese cohort (79% vs 30%). The IGH gene repartition between UM and M groups found in our study indicated the strong diversity between the two cohorts, providing a biological explanation for the more aggressive clinical course of Senegalese response to antigen stimulation, cell activation, and interaction with the microenvironment. 39 The engagement of surface immunoglobulin by antigen is currently hypothesized to be a key driver of malignant cells, and the interaction between neoplastic lymphocytes responding to BCR stimulation and the microenvironment might play a fundamental role in CLL pathogenesis. 2, 40 Of note, the analysis of surface immunoglobulin-mediated signaling has revealed bifurcation of responses toward proliferation or anergy in the two major disease subsets as defined by IGH mutational status (M vs UM). 41 Particularly, BCR signaling appeared more active in CLL with UM-IGH genes, while cases with M-IGH genes seemed to have responses resembling anergy. 42 M-CLL, the most common subtype in Western countries, in line with its relatively good prognosis, is thought to be mainly driven toward anergy in vivo by self-antigens. 43 In contrast, UM-CLL, the most common subtype in Africa, shows less evidence for anergy in vivo, retaining more responsiveness to surface immunoglobulin M-mediated signaling most likely by foreign antigens, thus possibly explaining the more aggressive clinical behavior. This may reflect not only intrinsic differences in the clones but also different interaction with T cells, likely in response to Toll-like receptor (TLR) stimulation. 44 Interestingly, TLRs are activated by recurrent malaria infections, which is common in the African population. Furthermore, most UM immunoglobulins, especially IGHV1-69, have been shown to be much more broadly reactive against bacteria than mutated ones. 45 The preferential usage of IGHV1-69 in Senegalese CLL might point to a polymicrobial nature of CLL in Africa, resulting in sustained activation of surface immunoglobulin signaling, earlier onset of the disease, and a more aggressive clinical behavior that is unlikely due only to the delay of diagnosis. However, it should be considered that the lack of access to health care may be a driver of the advanced clinical stage in African patients. This might be even more true for mutated cases where an indolent disease process progresses for many years before it becomes symptomatic. Furthermore, we cannot exclude that specific differences also exist between the two cohorts as far as the incidence of pathogenic somatic mutations is concerned, including those affecting TP53, NOTCH1, BIRC3, and SF3B1. In fact, the presence of mutations altering the function of these genes and the presence of a complex karyotype are well-known prognostic factors in CLL. Unfortunately, the lack of residual material did not allow a proper evaluation in this sense, which would be definitely warranted in the future.
We documented a diverse usage of IGH segments in Senegalese vs Italian cases. In particular, IGHV1 (IGHV1-69), IGHD3, and IGHJ6 were significantly more common in Senegalese cases, whereas IGHV3-30, common in Italians, was never observed. Stereotyped receptors commonly observed in the white population were not recorded in this African series. Finally, a shorter CDR3 was observed in rearrangements using IGHV3 family compared with other IGHV families. These findings are in line with a previous observation that longer CDR3 segments were associated with UM-CLL and adverse outcome and with the hypothesis that specific BCR is associated with more sustained antigen stimulation in CLL pathogenesis.
